Author:
Crispo James A. G.,Fortin Yannick,Thibault Dylan P.,Emons Matthew,Bjerre Lise M.,Kohen Dafna E.,Perez-Lloret Santiago,Mattison Donald,Willis Allison W.,Krewski Daniel
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference46 articles.
1. Callesen MB, Scheel-Kruger J, Kringelbach ML, Moller A (2013) A systematic review of impulse control disorders in Parkinson’s disease. J Park Dis 3:105–138
2. Weintraub D, Nirenberg MJ (2013) Impulse control and related disorders in Parkinson’s disease. Neurodegener Dis 11:63–71
3. Antonini A, Poewe W (2007) Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson’s disease. Lancet Neurol 6:826–829
4. Hsieh PH, Hsiao FY (2013) Risk of heart failure associated with dopamine agonists: a nested case–control study. Drugs Aging 30:739–745
5. Mokhles MM, Trifiro G, Dieleman JP, Haag MD, van Soest EM, Verhamme KM, Mazzaglia G, Herings R, Luise C, Ross D, Brusselle G, Colao A, Haverkamp W, Schade R, Camp G, Zanettini R, Sturkenboom MC (2012) The risk of new onset heart failure associated with dopamine agonist use in Parkinson’s disease. Pharmacol Res Off J Ital Pharmacol Soc 65:358–364
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献